Skip to main content
Renalytix Plc (RNLX)
NASDAQ: RNLX · IEX Real-Time Price · USD
0.253
+0.002 (0.80%)
At close: Jul 2, 2024, 3:59 PM
0.254
+0.001 (0.36%)
After-hours: Jul 2, 2024, 7:51 PM EDT

Renalytix Ratios and Metrics

Millions USD. Fiscal year is Jul - Jun.
Year
 Current2023202220212020
Market Capitalization
22109891,112-
Market Cap Growth
-52.58%23.22%-92.03%--
Enterprise Value
2697601,046-14
PE Ratio
--2.39-1.96-32.01-
PS Ratio
9.7432.0829.82745.60-
PB Ratio
-3.8715.672.8915.56-
P/FCF Ratio
-1.39-3.20-1.90-37.15-
P/OCF Ratio
-1.39-3.20-1.93-39.15-
EV/Sales Ratio
11.8628.3820.04701.87-
EV/EBITDA Ratio
-1.29-2.15-1.33-30.381.43
EV/EBIT Ratio
-1.27-2.12-1.32-30.141.42
EV/FCF Ratio
-1.54-2.83-1.28-34.971.30
Debt / Equity Ratio
-0.851.740.40-0.02
Debt / EBITDA Ratio
-0.25-0.27-0.28--0.03
Debt / FCF Ratio
-0.30-0.36-0.26--0.02
Quick Ratio
0.351.583.599.324.34
Current Ratio
0.421.673.809.464.51
Asset Turnover
0.130.100.060.020
Return on Equity (ROE)
1103.30%-345.60%-109.20%-42.40%-80.50%
Return on Assets (ROA)
-213.60%-130.50%-83.80%-40.10%-64.40%
Return on Capital (ROIC)
2010.46%-221.21%-123.83%-44.66%-63.80%
Earnings Yield
-173.30%-41.78%-51.11%-3.12%-
FCF Yield
-142.95%-31.23%-52.59%-2.69%-
Buyback Yield / Dilution
-14.14%-11.34%-3.29%-21.00%-38.81%
Total Shareholder Return
-14.14%-11.34%-3.29%-21.00%-38.81%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).